Equities

Nawaloka Hospitals PLC

NHL.N0000:CSE

Nawaloka Hospitals PLC

Actions
Health CareHealth Care Providers
  • Price (LKR)4.10
  • Today's Change0.10 / 2.50%
  • Shares traded40.67k
  • 1 Year change-18.00%
  • Beta--
Data delayed at least 15 minutes, as of May 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nawaloka Hospitals PLC is a Sri Lanka-based private healthcare services provider, delivering primary, secondary and tertiary healthcare services. The Company's segments include hospital services, pharmaceuticals, laboratories and radiology services. The Company is engaged in providing hospital services to inpatient and outpatient. It is engaged in the sale of pharmaceuticals, and provision of laboratories and radiographical services. Its clinics include physiotherapy, eye care and blood bank. Its physiotherapy clinics provide various services, such as pain management, physiotherapy rehabilitation, therapeutic treatments, and antenatal and postnatal physiotherapy care. The Company's eye care services include eye investigations, refractive services, treatment of various eye conditions (dry eyes, glaucoma and others), surgical procedures, lasik treatments and optical needs. It provides various surgery services, such as general surgery, electromyogram and digital X-ray, among others.

  • Revenue in LKR (TTM)10.27bn
  • Net income in LKR-1.99bn
  • Incorporated1982
  • Employees2.30k
  • Location
    Nawaloka Hospitals PLCNo. 23Deshamanya H. K Dharmadasa MawathaColombo 2COLOMBO Sri LankaLKA
  • Phone+94 112544444
  • Fax+94 112430393
  • Websitehttps://www.nawaloka.com/
More ▼

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Ceybank Asset Management Ltd.as of 31 Mar 20170.000.00%
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.